On January 17, 2024, Rajeev Shah notified Black Diamond Therapeutics, Inc. of his intent to resign from the Company's Board of Directors (the Board"), including his position as a member of the Audit Committee of the Board, effective immediately. Mr. Shah served as a member of the Board since December 2018. Mr. Shah's decision to resign from the Board was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.11 USD | -9.48% | -12.21% | +117.44% |
05-09 | Black Diamond Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Black Diamond Therapeutics, Inc. Announces Board and Committee Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+117.44% | 321M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- BDTX Stock
- News Black Diamond Therapeutics, Inc.
- Black Diamond Therapeutics, Inc. Announces Resignation of Rajeev Shah from Board of Directors, Including as A Member of the Audit Committee of the Board